AMGN: Amgen Inc. Stock Live Price Graph
Amgen Inc. stock live price (US Dollar), charts and analysis. Get AMGN stock market news.
Amgen Inc. (AMGN)
Loading chart...
About the company
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.
Company profile
Market News & Analysis
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $2.52 | $2.52 | 2.26% | - |
What Is AMGN? Live AMGN Prices and Analysis
AMGN, or Amgen Inc., is a leading biotechnology company that develops and manufactures human therapeutics. Established in 1980, Amgen has become one of the largest independent biotechnology companies globally, focusing on innovative medicines that address serious illnesses. Investors closely follow AMGN due to its significant role in the healthcare sector and its impact on biotechnology stock performance.
As a prominent player in the biotechnology industry, AMGN's performance is crucial not only for its shareholders but also for understanding trends in the broader healthcare market. The company's advancements in drug development and the introduction of new therapies can drive stock prices, making it an essential asset for investors seeking exposure to biotech.
Frequently asked questions
What is the AMGN stock price?
The latest AMGN (Amgen Inc. (AMGN)) stock price is 413.0800 USD. Follow the live quote and chart on this page for real-time updates.
What are AMGN's intraday ceiling and floor prices?
For AMGN, the intraday ceiling is 415.7900 USD and the floor is 401.8500 USD. These levels may update during the session.
What is AMGN's previous closing price?
The previous closing price for AMGN is 402.6000 USD.
What is AMGN's trading volume?
The current trading volume for AMGN is 2,218,937. Volume can change throughout the session.
Where can I see the live AMGN price?
You can follow the live AMGN (Amgen Inc. (AMGN)) price in the quote area and chart at the top of this Investvio overview page.
Where can I see AMGN historical prices and charts?
The current price chart for AMGN (Amgen Inc. (AMGN)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.